Repositioning of Ertiprotafib via supramolecular assembly enables biomarker-guided therapy for acute kidney injury

Authors:

Abstract
Acute kidney injury (AKI) is a rapid loss of renal function that has become a global health concern, with incidence rates reaching up to 50% in critically
Funding Information
  • National Research Foundation of Korea (RS-2025-02219039, RS-2024-00452747, RS-2022-NR070224 and RS-2025-02218875)
  • Korea Institute of Science and Technology (Intramural Research Program)

This publication has 41 references indexed in Scilit: